A Clinical Trial Comparing Short-Term Efficacy and Safety of Exubera and Lantus

• Status: Completed
• Trial end date: 2007-02-01
• Target enrollment: 0
• Participant gender: All

Summary

To compare short-term efficacy and safety of Exubera vs Lantus in patients with type 2 diabetes mellitus

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Insulin; Insulin Glargine; Insulin, Globin Zinc

Criteria

Inclusion Criteria:

• Diabetes mellitus Type 2

Exclusion Criteria:

• Severe Asthma, severe COPD

• Smoking